NCT06275464View on ClinicalTrials.gov

BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

April 18, 2024

Study Completion Date

April 23, 2024

Conditions
Healthy
Interventions
COMBINATION_PRODUCT

BT-600

NaviCap device containing liquid formulation of Tofacitinib

COMBINATION_PRODUCT

BT-600 Placebo

NaviCap device containing placebo formulation

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Biora Therapeutics, Inc.

INDUSTRY